Savior Lifetec Competitors and Similar CompaniesClear all

Savior Lifetec's competitors and similar companies include Sun Pharma, Torrent Pharmaceuticals, Hikma Pharmaceuticals and Divis Laboratories.

	Savior Lifetec Savior Lifetec Corporation (SLC, 松瑞製藥股份有限公司) is a company specializing in the development, production, and sale of active pharmaceutical ingredients interfaces and injectables.	Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.	Torrent Pharmaceuticals Manufactures wide range of pharmaceutical products.	Hikma Pharmaceuticals Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.	Divis Laboratories Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates.
Founding Date	Founding Date 2004	Founding Date 1983	Founding Date 1971	Founding Date 1978	Founding Date 1990
Type	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare pharma	Tags Healthcare pharma	Tags Healthcare pharma
Locations	Locations Taipei, TW HQ	Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more	Locations Ahmedabad, IN HQ São Paulo, BR Nürnberg, DE 32 No Market, IN Bengaluru, IN Chennai, IN Dahej, IN see more	Locations London, GB HQ Staoueli, DZ Mississauga, CA Boulogne Billancourt, FR Martinsried, DE Pavia, IT Amman, JO see more	Locations Hyderabad, IN HQ Choutuppal, IN Thondangi, IN Visakhapatnam, IN Basel, CH Basel, CH Florham Park, US
Employees	Employees 2907% decrease	Employees 43,000	Employees 15,718	Employees 9,500	Employees 7,9267% increase
Financial
Revenue (est.)	Revenue (est.) NT$1.2b (FY, 2024)	Revenue (est.) ₹582.2b (FY, 2026)	Revenue (est.) ₹137.5b (FY, 2026)	Revenue (est.) $3.3b (FY, 2025)	Revenue (est.) ₹105.6b (FY, 2026)
Cost of goods	Cost of goods NT$743.6m (FY, 2024)	Cost of goods ₹115.4b (FY, 2026)	Cost of goods ₹33.9b (FY, 2026)	Cost of goods $1.7b (FY, 2025)	Cost of goods ₹40.9b (FY, 2026)
Gross profit	Gross profit NT$487m (FY, 2024)	Gross profit ₹488.9b (FY, 2026)	Gross profit ₹105b (FY, 2026)	Gross profit $1.7b (FY, 2025)	Gross profit ₹69.7b (FY, 2026)
Net income	Net income NT$178.4m (FY, 2024)	Net income ₹115.6b (FY, 2026)	Net income ₹21.4b (FY, 2026)	Net income $407m (FY, 2025)	Net income ₹25.7b (FY, 2026)